ArticleScientific reports2025
Geographical variation in antioxidant, anticancer and anticholinesterase activities and phenolic contents of Visnaga daucoides.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visnaga daucoides (Desf.) Celak. (Apiaceae) is a plant known for its medicinal properties, but its phenolic content and biological activities remain underexplored, especially in relation to samples from different geographical regions. Exploring how environmental conditions may influence the plant's bioactive profile can provide valuable insights for its potential medicinal use. This study investigates the phenolic profile, antioxidant, anticholinesterase, and antiproliferative activities of V. daucoides collected from Iraq and Türkiye. In this study, the phenolic composition of Visnaga daucoides was determined by LC-MS/MS analysis. Antioxidant status was evaluated using TAS, TOS and OSI analyses, while antiproliferative activity was evaluated by MTT method on A549 lung cancer cells. Anticholinesterase activity was measured using Ellman method and antimicrobial activity was tested using agar dilution analysis. LC-MS/MS analysis revealed significant phenolic compounds, including acetohydroxamic acid, kaempferol, quercetin, gallic acid, and resveratrol, with geographical differences observed between the two regions. The plant exhibited potent antioxidant activity, as demonstrated by variations in total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI), which were determined using Rel Assay diagnostic kits. Furthermore, V. daucoides displayed notable antiproliferative effects, particularly against A549 lung cancer cells, and strong anticholinesterase activity, with inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). These findings suggest that V. daucoides is a promising source of bioactive compounds with potential applications in cancer therapy, neuroprotection, and oxidative stress management. The study also emphasizes the influence of environmental factors on the chemical composition and biological activities of the plant, warranting further investigation into its pharmacological potential for therapeutic use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.